Antisense Therapeutics

Follow
Get notifications in MyBN when activity occurs. Upgrade your subscription to use this feature.

Company Activity

Gil Price
NEW ROLE: Gil Price, Consultant Medical Director, Non-Executive Director since 202111 Oct 2021
Default
NEW ROLE: Alicia Mellors, Joint Company Secretary29 Mar 2021
Charmaine Gittleson
NEW ROLE: Charmaine Gittleson, Non-Executive Chair29 Mar 2021
Default
NEW ROLE: Nuket Desem, Director-Clinical & Regulatory Affairs24 Nov 2020
Default
NEW ROLE: George Tachas, Director Drug Discovery and Patents24 Nov 2020
Graham Mitchell
NEW ROLE: Graham Mitchell, Non-Executive Director03 Nov 2020
Gary Pace
NEW ROLE: Gary Pace, Non-Executive Director03 Nov 2020
Default
NEW ROLE: Robert Moses, Non-Executive Director, was Chair 2001-202103 Nov 2020
Mark Diamond
NEW ROLE: Mark Diamond, Chief Executive, Managing Director03 Nov 2020
Default
NEW ROLE: William Goolsbee, Non-Executive Director03 Nov 2020

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options